Picture of Cencora logo

COR — Cencora News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Cencora's CFO Cleary to retire, shares down

Updates

** Shares of drug distributor Cencora COR.N fall 3.4% to $334.01

** Cencora says James Cleary will retire as Chief Financial Officer on June 30

** Says it has engaged an executive search firm to identify and evaluate potential successors from internal and external candidates

** Adds Cleary will assist in the search process and serve as an adviser through the end of 2026

** We view his continued involvement through the transition period as a positive, supporting continuity and execution - Evercore ISI

** His retirement comes as a surprise to us, but with Cleary staying in an advisory capacity through the end of 2026, we think he will be able to work with his successor ahead of providing FY27 guidance in the fall - J.P. Morgan

** Cencora reaffirms annual adjusted EPS forecast of $17.45 to $17.75

** Analysts, on average, expect annual adjusted EPS of $17.62 per share, according to data compiled by LSEG

** Including session's moves, stock down 1.4% YTD

 (Reporting by Siddhi Mahatole)

 ((siddhi.mahatole@thomsonreuters.com))

Recent news on Cencora

See all news